Search alternatives:
point decrease » point increase (Expand Search)
min decrease » mean decrease (Expand Search), gain decreased (Expand Search), fid decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
6 min » 60 min (Expand Search), 5 min (Expand Search), 1 min (Expand Search)
point decrease » point increase (Expand Search)
min decrease » mean decrease (Expand Search), gain decreased (Expand Search), fid decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
6 min » 60 min (Expand Search), 5 min (Expand Search), 1 min (Expand Search)
-
21
Viability of MIN6 cell lines treated with various pharmacological reagents.
Published 2023Subjects: -
22
-
23
The effect of investigated leucettines on the level of DYRK1A in MIN6 cells.
Published 2023Subjects: -
24
The influence of selected leucettines on insulin production by 3D MIN6 spheroids.
Published 2023Subjects: -
25
-
26
Downregulation of DOM decreases the abundance of PER and TIM.
Published 2019“…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”
-
27
-
28
-
29
-
30
-
31
Mitochondrial dysfunction is driven by decreased mitochondrial dynamics.
Published 2014“…<p>(A) Sensitivity analysis averaged along the time course for the mitochondrial species in the model by varying the mitochondrial-related kinetic rate constant parameters. …”
-
32
-
33
-
34
PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis
Published 2016“…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …”
-
35
-
36
-
37
Decreased 11ß-HSD1 protein level by IGF-I overexpression <i>in vivo</i> and a direct treatment with IGF-I.
Published 2015“…IGF-I treatment accelerated 11β-HSD1 protein degradation in 11β-HSD1 overexpressing MIN6 cells (as in Figs <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0136656#pone.0136656.g005" target="_blank">5</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0136656#pone.0136656.g006" target="_blank">6</a>). …”
-
38
-
39
-
40